VIR
Vir Biotechnology Inc
10.70$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -23.8% | +167.3% | +79.4% | +112.7% | +43.4% | -31.5% | -27.1% | -28.3% | |
| – | -38.8% | +242.2% | +91.7% | +102.3% | +61.2% | -37.0% | -34.4% | -50.7% | |
| – | -74.7% | +129.7% | +299.3% | -20.3% | +144.0% | -71.5% | -7.7% | +5.0% | |
| – | -47.6% | +289.5% | +92.2% | -3.9% | +239.2% | -36.6% | -40.5% | -48.9% | |
| – | – | – | – | +40,588.4% | -96.6% | -56.1% | -56.0% | -29.4% | |
| – | – | – | – | – | – | – | – | – | |
| – | +139.2% | +32.7% | +10.0% | +624.7% | +44.7% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +2.9% | -3.3% | -5.3% | -1.6% | -1.6% | -31.1% | -64.1% | -3.1% | |
| – | +15.7% | -76.2% | +129.1% | +158.7% | +38.6% | -54.6% | -24.4% | -4.4% | |
| – | +220.9% | +48.4% | +67.3% | +244.5% | +49.8% | -65.7% | -31.8% | -22.4% | |
| – | – | -98.4% | +1,429.5% | +8.3% | +5.3% | +211.0% | -39.8% | +13.5% | |
| – | +32.2% | -9.1% | -13.7% | +28.4% | -1.5% | -1.4% | -19.8% | +92.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +69.1% | +99.7% | +45.1% | -23.5% | -27.7% | -33.5% | |
| – | – | – | – | – | – | -163.0% | – | – | |
| – | +1,289.7% | +11.1% | +10.7% | +12.0% | +1.0% | -0.5% | +1.6% | +1.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.